This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denis, C L
Right arrow Articles by Bemis, L T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denis, C L
Right arrow Articles by Bemis, L T

 Previous Article  |  Next Article 

Mol Cell Biol. 1992 April; 12(4): 1507-1514

ADR1c mutations enhance the ability of ADR1 to activate transcription by a mechanism that is independent of effects on cyclic AMP-dependent protein kinase phosphorylation of Ser-230.

C L Denis, S C Fontaine, D Chase, B E Kemp and L T Bemis

Department of Biochemistry and Molecular Biology, University of New Hampshire, Durham 03824.

ABSTRACT

Four ADR1c mutations that occur close to Ser-230 of the Saccharomyces cerevisiae transcriptional activator ADR1 and which greatly enhance the ability of ADR1 to activate ADH2 expression under glucose-repressed conditions have been shown to reduce or eliminate cyclic AMP-dependent protein kinase (cAPK) phosphorylation of Ser-230 in vitro. In addition, unregulated cAPK expression in vivo blocks ADH2 depression in an ADR1-dependent fashion in which ADR1c mutations display decreased sensitivity to unregulated cAPK activity. Taken together, these data have suggested that ADR1c mutations enhance ADR1 activity by blocking cAPK phosphorylation and inactivation of Ser-230. We have isolated and characterized an additional 17 ADR1c mutations, defining 10 different amino acid changes, that were located in the region defined by amino acids 227 through 239 of ADR1. Three observations, however, indicate that the ADR1c phenotype is not simply equivalent to a lack of cAPK phosphorylation. First, only some of these newly isolated ADR1c mutations affected the ability of yeast cAPK to phosphorylate corresponding synthetic peptides modeled on the 222 to 234 region of ADR1 in vitro. Second, we observed that strains lacking cAPK activity did not display enhanced ADH2 expression under glucose growth conditions. Third, when Ser-230 was mutated to a nonphosphorylatable residue, lack of cAPK activity led to a substantial increase in ADH2 expression under glucose-repressed conditions. Thus, while cAPK controls ADH2 expression and ADR1 is required for this control, cAPK acts by a mechanism that is independent of effects on ADR1 Ser-230. It was also observed that deletion of the ADR1c region resulted in an ADR1c phenotype. The ADR1c region is, therefore, involved in maintaining ADR1 in an inactive form. ADR1c mutations may block the binding of a repressor to ADR1 or alter the structure of ADR1 so that transcriptional activation regions become unmasked.

Mol Cell Biol. 1992 April; 12(4): 1507-1514




This article has been cited by other articles:

  • Ratnakumar, S., Kacherovsky, N., Arms, E., Young, E. T. (2009). Snf1 Controls the Activity of Adr1 Through Dephosphorylation of Ser230. Genetics 182: 735-745 [Abstract] [Full Text]  
  • Young, E. T., Tachibana, C., Chang, H.-W. E., Dombek, K. M., Arms, E. M., Biddick, R. (2008). Artificial Recruitment of Mediator by the DNA-Binding Domain of Adr1 Overcomes Glucose Repression of ADH2 Expression. Mol. Cell. Biol. 28: 2509-2516 [Abstract] [Full Text]  
  • Tachibana, C., Biddick, R., Law, G. L., Young, E. T. (2007). A Poised Initiation Complex Is Activated by SNF1. J. Biol. Chem. 282: 37308-37315 [Abstract] [Full Text]  
  • Lin-Cereghino, G. P., Godfrey, L., de la Cruz, B. J., Johnson, S., Khuongsathiene, S., Tolstorukov, I., Yan, M., Lin-Cereghino, J., Veenhuis, M., Subramani, S., Cregg, J. M. (2006). Mxr1p, a Key Regulator of the Methanol Utilization Pathway and Peroxisomal Genes in Pichia pastoris. Mol. Cell. Biol. 26: 883-897 [Abstract] [Full Text]  
  • Young, E. T., Kacherovsky, N., Van Riper, K. (2002). Snf1 Protein Kinase Regulates Adr1 Binding to Chromatin but Not Transcription Activation. J. Biol. Chem. 277: 38095-38103 [Abstract] [Full Text]  
  • Joseph, J. D., Means, A. R. (2002). Calcium Binding Is Required for Calmodulin Function in Aspergillus nidulans. Eukaryot Cell 1: 119-125 [Abstract] [Full Text]  
  • Sloan, J. S., Dombek, K. M., Young, E. T. (1999). Post-translational Regulation of Adr1 Activity Is Mediated by Its DNA Binding Domain. J. Biol. Chem. 274: 37575-37582 [Abstract] [Full Text]  
  • Dombek, K. M., Voronkova, V., Raney, A., Young, E. T. (1999). Functional Analysis of the Yeast Glc7-Binding Protein Reg1 Identifies a Protein Phosphatase Type 1-Binding Motif as Essential for Repression of ADH2 Expression. Mol. Cell. Biol. 19: 6029-6040 [Abstract] [Full Text]  
  • Hook, S. S., Kemp, B. E., Means, A. R. (1999). Peptide Specificity Determinants at P-7 and P-6 Enhance the Catalytic Efficiency of Ca2+/Calmodulin-dependent Protein Kinase I in the Absence of Activation Loop Phosphorylation. J. Biol. Chem. 274: 20215-20222 [Abstract] [Full Text]  
  • Young, E. T., Saario, J., Kacherovsky, N., Chao, A., Sloan, J. S., Dombek, K. M. (1998). Characterization of a p53-related Activation Domain in Adr1p That Is Sufficient for ADR1-dependent Gene Expression. J. Biol. Chem. 273: 32080-32087 [Abstract] [Full Text]  
  • Komarnitsky, P. B., Klebanow, E. R., Weil, P. A., Denis, C. L. (1998). ADR1-Mediated Transcriptional Activation Requires the Presence of an Intact TFIID Complex. Mol. Cell. Biol. 18: 5861-5867 [Abstract] [Full Text]  
  • Gancedo, J. M. (1998). Yeast Carbon Catabolite Repression. Microbiol. Mol. Biol. Rev. 62: 334-361 [Abstract] [Full Text]  
  • Verdone, L., Cesari, F., Denis, C. L., Di Mauro, E., Caserta, M. (1997). Factors Affecting Saccharomyces cerevisiae ADH2 Chromatin Remodeling and Transcription. J. Biol. Chem. 272: 30828-30834 [Abstract] [Full Text]  
  • Bellaiche, Y, Bandyopadhyay, R, Desplan, C, Dostatni, N (1996). Neither the homeodomain nor the activation domain of Bicoid is specifically required for its down-regulation by the Torso receptor tyrosine kinase cascade. Development 122: 3499-3508 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»